Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Faire, Neuralink, and 370+ companies. 5-min read every Tuesday.
Faire is the wholesale marketplace connecting 700K+ independent retailers with 100K+ emerging brands — the B2B commerce platform for the indie retail economy. Valued at $12.4B with $1.7B raised, Faire processes billions in annual GMV and is the dominant wholesale marketplace globally. IPO candidate as B2B commerce digitisation continues to disrupt traditional wholesale distribution — a $50B+ global market.
| Industry | E-commerce |
| Stage | Series H |
| IPO Status | Private |
| Valuation | $12.4B |
| Total Funding | $1.7B |
| Headquarters | San Francisco, CA |
Brain-computer interface company developing implantable chips (Telepathy device). Raised $650M Series E at $9B valuation (June 2025). CEO Elon Musk has no IPO plans — company is focused on FDA clinical trials, not public markets.
| Industry | Healthcare Technology |
| Stage | Series G |
| IPO Status | Private |
| Valuation | $15.0B |
| Total Funding | $2.6B |
| Headquarters | Austin, TX |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Faire is valued at $12.4B. Neuralink is valued at $15.0B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Faire filed an S-1 in April 2026 and is actively in the IPO pipeline. Neuralink is currently private. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Faire has raised $1.7B. Neuralink has raised $2.6B.
Faire operates in E-commerce, while Neuralink operates in Healthcare Technology.
Faire is a E-commerce company valued at $12.4B with $1.7B raised. Neuralink is a Healthcare Technology company valued at $15.0B with $2.6B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Faire and Neuralink through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.